Cargando…

PEGylated biologics in haemophilia treatment: Current understanding of their long‐term safety

Detalles Bibliográficos
Autor principal: Baumann, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027893/
https://www.ncbi.nlm.nih.gov/pubmed/31742794
http://dx.doi.org/10.1111/hae.13875
_version_ 1783498928319102976
author Baumann, Andreas
author_facet Baumann, Andreas
author_sort Baumann, Andreas
collection PubMed
description
format Online
Article
Text
id pubmed-7027893
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70278932020-02-24 PEGylated biologics in haemophilia treatment: Current understanding of their long‐term safety Baumann, Andreas Haemophilia Letters to the Editor John Wiley and Sons Inc. 2019-11-19 2020-01 /pmc/articles/PMC7027893/ /pubmed/31742794 http://dx.doi.org/10.1111/hae.13875 Text en © 2019 The Authors. Haemophilia published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Letters to the Editor
Baumann, Andreas
PEGylated biologics in haemophilia treatment: Current understanding of their long‐term safety
title PEGylated biologics in haemophilia treatment: Current understanding of their long‐term safety
title_full PEGylated biologics in haemophilia treatment: Current understanding of their long‐term safety
title_fullStr PEGylated biologics in haemophilia treatment: Current understanding of their long‐term safety
title_full_unstemmed PEGylated biologics in haemophilia treatment: Current understanding of their long‐term safety
title_short PEGylated biologics in haemophilia treatment: Current understanding of their long‐term safety
title_sort pegylated biologics in haemophilia treatment: current understanding of their long‐term safety
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027893/
https://www.ncbi.nlm.nih.gov/pubmed/31742794
http://dx.doi.org/10.1111/hae.13875
work_keys_str_mv AT baumannandreas pegylatedbiologicsinhaemophiliatreatmentcurrentunderstandingoftheirlongtermsafety